Chloramphenicol 3. Clinical pharmacology of systemic use in the horse.
The use of chloramphenicol in the horse is now prohibited as horses are classified as food-producing animals. However, chloramphenicol has until recently been widely available for oral, intramuscular or intravenous administration. A critical appraisal of the published literature on the use of chloramphenicol in the horse clearly demonstrates that there are sound pharmacokinetic and microbiological reasons for concluding that chloramphenicol is not an appropriate antibiotic for systemic use. The short half-life of chloramphenicol in the horse, together with the broad range of minimum inhibitory concentrations of target pathogens, preclude the use of practical dosage regimens. It can be concluded that the withdrawal of chloramphenicol will have no adverse effects on chemotherapy in the horse.
Page
S W
SW
Australian Veterinary Association Subcommittee on Therapeutics, Artarmon, New South Wales.
D000818:Animals; D002701:Chloramphenicol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006207:Half-Life; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses / Q000378:metabolism*
D002701:Chloramphenicol